Skip to main content Skip to main navigation menu Skip to site footer
logo Mediterranean Journal of Hematology and Infectious Diseases

eISSN 2035-3006

  • Home
  • About the Journal
  • Editorial Board
  • Current
  • Archives
  • Announcements
  • Register
  • Login
  • Journal Statistics
  • Search
  • Contact
  • Announcements

Editor-in-Chief: Giuseppe Leone | Italy

2.3
Impact Factor 2025
3.2
CiteScore 2025
2.3
Impact Factor 2025
3.2
CiteScore 2025
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • THERAPY-RELATED MYELOID MALIGNANCIES IN MYELOMA

    Xenofon Papanikolaou, Bart Barlogie, Saad Usmani
    e2011047
    2011-10-24
    https://doi.org/10.4084/mjhid.2011.047
    2517
    PDF: 802
    HTML: 1742
  • CHLORAMBUCIL PLUS RITUXIMAB AS FRONT-LINE THERAPY IN ELDERLY/UNFIT PATIENTS AFFECTED BY B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA: RESULTS OF A SINGLE-CENTRE EXPERIENCE.

    Luca Laurenti, Barbara Vannata, Idanna Innocenti, Francesco Autore, Francesco Santini, Nicola Piccirillo, Tommaso Za, Silvia Bellesi, Sara Marietti, Simona Sica, Dimitar G. Efremov, Giuseppe Leone
    e2013031
    2013-05-01
    https://doi.org/10.4084/mjhid.2013.031
    3286
    PDF: 916
    HTML: 1549
    Fig.1 CHL-R paper: 228
    Fig 2 CHL-R paper: 252
  • RENAL ABNORMALITIES AMONG SICKLE CELL DISEASE PATIENTS IN A POOR MANAGEMENT SETTING: A SURVEY IN THE DEMOCRATIC REPUBLIC OF THE CONGO

    Paul Kambale-Kombi, Roland Marini Djang’eing’a, Jean-Pierre Alworong’a Opara, Jean-Paulin Mbo Mukonkole, Vincent Bours, Dieu-Merci Mbumba Lupaka, Serge Tonen-Wolyec, Lucien Bolukaoto Bome, Charles Kayembe Tshilumba, Salomon Batina-Agasa
    e2022046
    2022-06-29
    https://doi.org/10.4084/MJHID.2022.046
    932
    PDF: 684
    HTML: 362
  • DISTRIBUTION OF DIFFERENT PML/RAR? BCR ISOFORMS IN INDIAN ACUTE PROMYELOCYTIC LEUKAEMIA (APL) PATIENTS AND CLINICOHEMATOLOGICAL CORRELATION

    Tathagata Chatterjee, Srishti Gupta, Ajay Sharma, Sanjeevan Sharma, Prosenjit Ganguli
    e2014004
    2013-12-31
    https://doi.org/10.4084/mjhid.2014.004
    1522
    PDF: 929
    HTML: 2219
    Response to reviewers comments: 195
  • PLATELET-LEUKOCYTE INTERACTIONS : MULTIPLE LINKS BETWEEN INFLAMMATION , BLOOD COAGULATION AND VASCULAR RISK

    Chiara Cerletti, Giovanni de Gaetano, Roberto Lorenzet
    e2010023
    2010-08-06
    https://doi.org/10.4084/mjhid.2010.023
    1844
    PDF: 867
    HTML: 10410
  • WALDENSTRÖM MACROGLOBULINEMIA - A STATE-OF-THE-ART REVIEW: PART 2- FOCUS ON THERAPY

    Michele Bibas, Shayna Sarosiek , Jorge Castillo
    e2025015
    2025-02-27
    https://doi.org/10.4084/MJHID.2025.015
    2632
    PDF: 2048
    HTML: 238
  • Human T-cell leukemia virus type ? associated with an increased risk of primary malignant neoplasm

    Aya Nakaya, Shinya Fujita, Atsushi Satake, Takahisa Nakanishi, Yoshiko Azuma, Yukie Tsubokura, Akiko Konishi, Masaaki Hotta, Hideaki Yoshimura, Kazuyoshi Ishii, Tomoki Ito, Shosaku Nomura
    e2018024
    2018-04-20
    https://doi.org/10.4084/mjhid.2018.024
    2306
    PDF: 747
    HTML: 306
  • THE TRAGEDY CAUSED BY FAKE ANTIMALARIAL DRUGS

    Pierre Ambroise-Thomas
    e2012027
    2012-05-04
    https://doi.org/10.4084/mjhid.2012.027
    2818
    PDF: 1098
    HTML: 1933
  • PREVALENCE OF HPV HIGH-RISK GENOTYPES IN THREE COHORTS OF WOMEN IN OUAGADOUGOU (BURKINA FASO)

    Theodora M. Zohoncon, Jacques Simpore
    e2013059
    2013-09-01
    https://doi.org/10.4084/mjhid.2013.059
    1521
    PDF: 795
    HTML: 2003
  • CLINICAL ANALYSIS AND OPTIMIZATION OF POST-REMISSION THERAPY FOR ACUTE MYELOID LEUKEMIA PATIENTS WITH MINIMAL RESIDUAL DISEASE AS DETERMINED BY FLOW CYTOMETRY

    Daichi Inoue, Hayato Maruoka, Takayuki Takahashi
    e2010020
    2010-08-05
    https://doi.org/10.4084/mjhid.2010.020
    1317
    PDF: 757
    HTML: 1182
  • HEMATOLOGY PATIENT PROTECTION DURING THE COVID-19 PANDEMIC IN ITALY: A NATIONWIDE NURSING SURVEY Hematology patient protection during the COVID-19

    Stefano Botti, Nicola Serra, Fausto Castagnetti, Sabina Chiaretti, Nicola Mordini, Gianpaolo Gargiulo, Laura Orlando
    e2021011
    2021-01-01
    https://doi.org/10.4084/mjhid.2021.011
    1676
    PDF: 606
    HTML: 238
  • The correlation between ineffective erythropoiesis biomarkers and development of extramedullary hematopoiesis in patients with thalassemia

    Siriyakorn Chansai, Supawadee Yamsri, Supan Fucharoen, Goonnapa Fucharoen, Nattiya Teawtrakul
    e2022052
    2022-06-29
    https://doi.org/10.4084/MJHID.2022.052
    1174
    PDF: 495
    HTML: 238
  • PREVENTION OF ? THALASSEMIA IN NORTHERN ISRAEL - A COST-BENEFIT ANALYSIS.

    Ariel Koren, Lora Profeta, Luci Zalman, Haya Palmor, Carina Levin, Ronit Bril Zamir, Stavit Shalev, Orna Blondheim
    e2014012
    2014-02-17
    https://doi.org/10.4084/mjhid.2014.012
    2773
    PDF: 1259
    HTML: 11813
  • DIAGNOSTIC VALUE OF SIMULTANEOUS MEASUREMENT OF PROCALCITONIN, INTERLEUKIN-6 AND HS CRP IN PREDICTION OF EARLY-ONSET NEONATAL SEPSIS

    alireza abdollahi, saeed shoar, fatemeh nayyeri, mamak shariat
    e2012028
    2012-05-06
    https://doi.org/10.4084/mjhid.2012.028
    2087
    PDF: 1240
    HTML: 1940
    Untitled: 159
    TaBles Neinates sepsis: 192
  • HOW I TREAT NEWLY DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA

    Giuseppe Avvisati
    e2011064
    2011-12-19
    https://doi.org/10.4084/mjhid.2011.064
    13308
    PDF: 993
    HTML: 7300
  • Systemic lupus erythematosus, complicated by nephritis and macrophage activation syndrome, not responsive to high-dose immunosuppression

    Ioanna Saougou, Alexandros Makis
    e2026054
    2026-06-30
    https://doi.org/10.4084/MJHID.2026.054
    164
    PDF: 112
    HTML: 60
  • ROLE OF COMORBIDITIES IN OPTIMIZING DECISION-MAKING FOR ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION

    Mohamed L. Sorror, Rainer F. Storb
    e2010015
    2010-06-08
    https://doi.org/10.4084/mjhid.2010.015
    1026
    PDF: 647
    HTML: 2236
  • THE USE OF MONOCLONAL ANTIBODIES IN THE TREATMENT OF AUTOIMMUNE COMPLICATIONS OF CHRONIC LYMPHOCYTIC LEUKEMIA

    Luca Laurenti
    e2013027
    2013-04-10
    https://doi.org/10.4084/mjhid.2013.027
    2227
    PDF: 1053
    HTML: 2730
  • THE IMPACT OF THE SARS-CoV-2 PANDEMIC ON HEALTHCARE PROVISION IN ITALY TO NON-COVID PATIENTS: A SYSTEMATIC REVIEW

    Annarita Botta, Gianmarco Lugli, Matteo Maria Ottaviani, Guido Ascione, Alessandro Bruschi, Federico Cagnazzo, Lorenzo Zammarchi, Paola Romagnani, tommaso portaluri
    e2022012
    2022-01-01
    https://doi.org/10.4084/MJHID.2022.012
    1843
    PDF: 3333
    HTML: 433
  • EFFICACY AND SAFETY OF SINOPHARM VACCINE FOR SARS-COV-2 AND BREAKTHROUGH INFECTIONS IN IRANIAN PATIENTS WITH HEMOGLOBINOPATHIES: A PRELIMINARY REPORT Sinopharm Vaccination in Iranian Patients with Hemoglobinopathies

    Mehran Karimi, Tahereh Zarei, Sezaneh Haghpanah , Azita Azarkeiva, Maryam Naderi , Sara Matin , Asghar Bazrafshan , Zohreh Zahedi , Afshan Shirkavand , Parisa pishdad, Vincenzo De Sanctis
    e2022026
    2022-02-27
    https://doi.org/10.4084/MJHID.2022.026
    1738
    PDF: 746
    HTML: 237
  • BETA THALASSEMIA MAJOR IN A DEVELOPING COUNTRY: EPIDEMIOLOGICAL, CLINICAL AND EVOLUTIONARY ASPECT

    Mohamed Bejaoui, Naouel Guirat
    e2013002
    2013-01-01
    https://doi.org/10.4084/mjhid.2013.002
    1649
    PDF: 915
    HTML: 2516
  • REFRACTORY THROMBOCYTOPENIA AND NEUTROPENIA: A DIAGNOSTIC CHALLENGE

    Emmanuel Gyan, François Dreyfus, Pierre Fenaux
    e2015018
    2015-02-13
    https://doi.org/10.4084/mjhid.2015.018
    12578
    PDF: 1699
    HTML: 4233
    Cover letter: 209
    Figure 1: 216
  • The PARTIAL ACHIEVEMENT OF THE 90-90-90 UNAIDS TARGET IN A COHORT OF HIV INFECTED PATIENTS FROM CENTRAL ITALY.

    Elisabetta Schiaroli
    e2020017
    2020-02-26
    https://doi.org/10.4084/mjhid.2020.017
    1647
    PDF: 794
    HTML: 217
  • COMPARISON OF IL-34, ELASTOGRAPHY, AND BIOPSY IN THE ASSESSMENT OF LIVER FIBROSIS IN CHRONIC HEPATITIS B Evaluating Non-Invasive and Invasive Methods in Liver Fibrosis

    Vahibe Aydın Sarıkaya, gülşah Tunçer, sevim Özdemir, Rüştü Türkay, Burak Sarıkaya, Saime Gül Barut, Esen Gül Uzuner, Filiz Pehlivanoğlu
    e2025078
    2025-10-31
    https://doi.org/10.4084/MJHID.2025.078
    583
    PDF: 332
    Html: 29
  • DISTRIBUTION OF DNA DAMAGE REPAIR GENE POLYMORPHISM hOGG1, XRCC1 and p53 AMONG SICKLE CELL DISEASE PATIENTS IN INDIA

    Sudhansu Sekhar Nishank
    e2015046
    2015-07-02
    https://doi.org/10.4084/mjhid.2015.046
    1579
    PDF: 800
    HTML: 1493
    Table Genotype and allele frequencies of hOGG1 codon 326 Ser>Cys and p53 72Arg>Pro polymorphisms among SCD patients and control group: 186
  • PROGNOSTIC VALUE OF BRAIN AND ACUTE LEUKEMIA CYTOPLASMIC GENE EXPRESSION IN EGYPTIAN CHILDREN WITH ACUTE MYELOID LEUKEMIA

    adel abd elhaleim hagag
    e2015033
    2015-04-19
    https://doi.org/10.4084/mjhid.2015.033
    2139
    PDF: 845
    HTML: 1152
  • HODGKIN LYMPHOMA IN CHILDREN: A 16-YEAR EXPERIENCE AT THE CHILDREN’S WELFARE TEACHING HOSPITAL OF BAGHDAD, IRAQ

    Anna Maria Testi, Mazin Faisal Al-Jadiry, Maria Luisa Moleti, Stefania Uccini, Amir Fadhil Al-Darraij, Raghad Majid Al-Saeed, Hasanein Habeeb Ghali, Ahmed Hatem Sabhan, Samaher Abdulrazzaq Fadhil, Safaa Abdulelah Al-Badri, Adil Rabeea Alsaadawi, Ameer Dh Hameedi, Manhal Hashim Shanshal, Yasir Saadoon Al-Agele, Fatimah Abdul Ridha Al-Saffar, Nihal Khalid Yaseen, Alfonso Piciocchi, Giovanni Marsili, Salma Abbas Al-Hadad
    e2024053
    2024-06-29
    https://doi.org/10.4084/MJHID.2024.053
    1063
    PDF: 947
    Suppl. Files: 604
    HTML: 96
  • OPTIMIZING TREATMENT, MINIMIZING RISK: THERAPEUTIC DRUG MONITORING IN HEMATOLOGICAL MALIGNANCIES

    Jon Salmanton-Garcia, Francesco Marchesi, Oliver A. Cornely, Jannik Stemler, Pierantonio Menna
    2026-02-28
    https://doi.org/10.4084/MJHID.2026.022
    1354
    PDF: 1570
    Suppl. Files: 161
    HTML: 85
  • THE IMPACT OF CHEMOTHERAPY AFTER PEDIATRIC MALIGNANCY ON HUMORAL IMMUNITY TO VACCINE-PREVENTABLE DISEASES

    Chiara Garonzi, Rita Balter, Gloria Tridello, Anna Pegoraro, Manuela Pegoraro, Monia Pacenti, Novella Scattolo, Simone Cesaro
    e2020014
    2020-02-26
    https://doi.org/10.4084/mjhid.2020.014
    1670
    PDF: 1003
    HTML: 291
  • Coexisting Pulmonary Tuberculosis and Mucormycosis in a Patient with Aplastic Anemia Post Allogenic Stem Cell Transplantion

    Sanjeev Kumar Sharma, Narendra Agrawal, Anjan Mukherjee, Tulika Seth, Pravas Mishra, Immaculata Xess, Manoranjan Mahapatra, Sanjay Sharma
    e2011036
    2011-09-08
    https://doi.org/10.4084/mjhid.2011.036
    2134
    PDF: 717
    HTML: 887
  • IS ALLOGENEIC TRANPLANTATION AN OPTION IN PATIENTS AFFECTED BY CONCURRENT MYELOFIBROSIS AND CHRONIC MYELOID LEUKEMIA (CML)?

    Federica Sorà, Patrizia Chiusolo, Francesco autore, Sabrina Giammarco, luca laurenti, elisabetta metafuni, idanna innocenti, eugenio galli, andrea bacigalupo, simona sica
    e2021062
    2021-10-29
    https://doi.org/10.4084/MJHID.2021.062
    1270
    PDF: 489
    HTML: 169
  • VIRAL ETIOLOGY OF ACUTE RESPIRATORY INFECTIONS IN PEDIATRIC PATIENTS IN LEBANON

    Khaldoun Masoud, Ghassan Matar, Ghassan Dbaibo, Geoarge F Araj, Hasan Zaraket, Rima Hanna Wakim
    e2019059
    2019-10-30
    https://doi.org/10.4084/mjhid.2019.059
    1505
    PDF: 871
    HTML: 208
  • COAGULOPATHY IN BETA-THALASSEMIA: CURRENT UNDERSTANDING AND FUTURE PERSPECTIVES

    M. Domenica Cappellini, Khaled M. Musallam, Alessia Marcon, Ali Taher
    e2009029
    2009-12-28
    1197
    PDF: 492
    HTML: 8190
  • GREEK CONSENSUS ON CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) TREATMENT

    Sotirios Sachanas, Theodoros Vassilakopoulos, Maria Angelopoulou, sotirios Papageorgiou, Emmanouil Spanoudakis, Maria Bouzani, Maria Dimou, Panagiotis Panagiotidis
    e2025014
    2025-02-27
    https://doi.org/10.4084/MJHID.2025.014
    1443
    HTML: 162
    PDF: 892
  • OUTCOME OF ANTIFUNGAL COMBINATION THERAPY FOR INVASIVE MOLD INFECTIONS IN HEMATOLOGICAL PATIENTS IS INDEPENDENT OF THE CHOSEN COMBINATION

    Rafael Rojas, José R. Molina, Isidro Jarque, Miguel A. Sanz
    e2012011
    2012-02-10
    https://doi.org/10.4084/mjhid.2012.011
    1149
    PDF: 554
    HTML: 1702
    Figures: 179
    Fifures Sanz: 187
    tables Sanz: 188
    Untitled: 185
  • IS IT SAFE AND COST SAVING TO DEFER THE CD4+ CELL COUNT MONITORING IN STABLE PATIENTS ON ART WITH MORE THAN 350 OR 500 CELLS/µL?

    Benedetto Maurizio Celesia, Dr., Andrea Marino, Dr., Rosa Fontana del Vecchio, Dr., Roberto Bruno, Dr., Filippo Palermo, Professor, Maria Gussio, Dr., Giuseppe Nunnari, Professor, Bruno Cacopardo, Professor
    e2019063
    2019-10-30
    https://doi.org/10.4084/mjhid.2019.063
    1482
    PDF: 767
    HTML: 225
  • GENETIC HETEROGENEITY OF BETA GLOBIN MUTATIONS AMONG ASIAN-INDIANS AND IMPORTANCE IN GENETIC COUNSELLING AND DIAGNOSIS

    Ravindra Kumar, Kritanjali Singh, Inusha Panigrahi, Sarita Agarwal
    e2013003
    2013-01-01
    https://doi.org/10.4084/mjhid.2013.003
    1798
    PDF: 1309
    HTML: 11529
    Figure1: 182
    Figure 2: 186
  • Dose-modified lenalidomide induces sustained hematological response in patients with intermediate to high risk myelodysplasia

    Alhossain A. Khalafallah, Bernadene Fernandopulle, Terry Brain
    e2010012
    2010-05-31
    https://doi.org/10.4084/mjhid.2010.012
    1078
    PDF: 703
    HTML: 351
  • IMMUNOLOGY OF TUBERCULOSIS

    Federica Bozzano, Francesco Marras, Andrea De Maria
    e2014027
    2014-04-07
    https://doi.org/10.4084/mjhid.2014.027
    5462
    PDF: 2041
    HTML: 7344
    Untitled: 203
  • Mental well-being in patients with transfusion-dependent anemias and hemochromatosis during the SARS-CoV-2 pandemic

    Rachele Piperno, Gabriella Bertazioli, Ravasi Giulia, Raffaella Mariani, Alberto Piperno
    e2021024
    2021-02-26
    https://doi.org/10.4084/mjhid.2021.024
    1227
    PDF: 506
    HTML: 182
  • AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR HIGH-RISK ACUTE LYMPHOBLASTIC LEUKEMIA: NON-RANDOMIZED STUDY WITH A MAXIMUM FOLLOW-UP OF MORE THAN 22 YEARS

    Grzegorz Helbig, Malgorzata Krawczyk-Kulis, Malgorzata Kopera, Krystyna Jagoda, Patrycja Rzepka, Aleksandra Majewska-Tessar, Marta Hejla, Slawomira Kyrcz-Krzemien
    e2014047
    2014-06-29
    https://doi.org/10.4084/mjhid.2014.047
    1576
    PDF: 926
    HTML: 1969
    Figure: 183
    Tables: 195
    ALL revision 1: 269
    response to reviewer: 189
  • PREVALENCE AND FACTORS ASSOCIATED WITH HUMAN PARVOVIRUS B19 INFECTION IN SICKLE CELL PATIENTS HOSPITALIZED IN TANZANIA

    Florence Urio, Humphrey George, Furahini Tluway, Thomas B Nyambo, Bruno P Mmbando, Julie Makani
    e2019054
    2019-08-29
    https://doi.org/10.4084/mjhid.2019.054
    1705
    PDF: 1283
    HTML: 224
  • TRANSIENT ELASTOGRAPHY (TE) IS A USEFUL TOOL FOR ASSESSING THE RESPONSE OF LIVER IRON CHELATION IN SICKLE CELL DISEASE PATIENTS

    SOPHIA DELICOU
    e2018049
    2018-09-01
    https://doi.org/10.4084/mjhid.2018.049
    1600
    PDF: 842
    HTML: 198
  • ADVERSE PREGNANCY OUTCOMES IN SICKLE CELL TRAIT: A PROSPECTIVE COHORT STUDY EVALUATING CLINICAL AND HAEMATOLOGICAL PARAMETERS IN POSTPARTUM MOTHERS AND NEW-BORNS. Sickle cell trait pregnancy and outcomes

    r. Salam Al-Kindi
    e2023002
    2022-12-31
    https://doi.org/10.4084/MJHID.2023.002
    1475
    PDF: 1254
    HTML: 489
  • COMBINED MODALITY TREATMENT INCLUDING METHOTREXATE-BASED CHEMOTHERAPY FOR PRIMARY CEREBRAL NERVOUS SYSTEM LYMPHOMA: A SINGLE INSTITUTION EXPERIENCE

    Stefan Hohaus, Luciana Teofili, Mario Balducci, Stefania Manfrida, Angelo Pompucci, Francesco D'Alo', Giuseppina Massini, Luigi Maria Larocca, Roberto Marra, Sergio Storti
    e2009020
    2009-12-14
    https://doi.org/10.4084/mjhid.2009.020
    2265
    PDF: 540
    HTML: 2292
  • HEMATOPOIETIC STEM CELL TRANSPLANTATION IN EGYPT CHALLENGES AND OPPORTUNITIES

    Hossam Kamel Mahmoud, Gamaleldin Mohamed Fathy, Alaa Elhaddad, Omar Abdelrahman Fahmy, Mohamed Abdelmooti, Raafat Abdelfattah, Mahmoud Tarek Sayed Ahmed Bokhary
    e2020023
    2020-04-27
    https://doi.org/10.4084/mjhid.2020.023
    1900
    PDF: 998
    HTML: 793
  • PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations

    Michele Bibas
    e2024007
    2024-01-01
    https://doi.org/10.4084/MJHID.2024.007
    3628
    PDF: 2552
    HTML: 1525
  • The COVID-19 in Omani children with chronic Hemato-oncology diseases COVID-19 in Omani children with chronic Hemato-oncology diseases

    Laila Al Yazidi
    e2020074
    2020-10-27
    https://doi.org/10.4084/mjhid.2020.074
    920
    PDF: 708
    HTML: 327
  • COMPARISON OF PRESEPSIN, PROCALCITONIN, INTERLEUKIN-8 AND C-REACTIVE PROTEIN IN PREDICTING BACTERAEMIA IN FEBRILE NEUTROPENIC ADULT PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES

    Irena Kostic, Carmela Gurrieri, Elisa Piva, Gianpietro Semenzato, Mario Plebani, Ilaria Caputo, Fabrizio Vianello
    e2019047
    2019-08-29
    https://doi.org/10.4084/mjhid.2019.047
    1827
    PDF: 1298
    HTML: 374
  • THE BIOLOGY OF MYCOBACTERIUM TUBERCULOSIS INFECTION.

    Giovanni Delogu, Michela Sali, Giovanni Fadda
    e2013070
    2013-11-15
    https://doi.org/10.4084/mjhid.2013.070
    10749
    PDF: 6461
    HTML: 21824
251 - 300 of 302 items << < 1 2 3 4 5 6 7 > >> 
Make a Submission

Links

  • Editorial Board
  • Alert me!
  • Advertising
  • Scopus
  • DOAJ
  • Article Processing Charge

Information

  • For Readers
  • For Authors
  • For Librarians

Indexing

  • OpenAlex
  • Analytics

PubMed

MJHID CiteScore by Scopus

Clarivate Analytics

this journal is covered
by Clarivate Analytics

 

The Mediterranean Journal of Hematology and Infectious Diseases has been selected for coverage in Clarivate Analytics products and services. Beginning with V. 7 (1) 2015.

AskBisht

Indexed in AskBisht.com

Facebook

FOLLOW US

MJHID in EuroPub Database

EuroPub

CLL UpDate

Keywords

Mediterranean Journal of Hematology and Infectious Diseases

is owned by the U.C.S.C. and it is published by PAGEPress®, Pavia, Italy. The MJHID is indexed and abstracted in Science Citation Index Expanded and Journal Citation Reports/InCites beginning with V. 7 (1) 2015.

eISSN: 2035-3006

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185
This journal is published by PAGEPress® srl (Pavia, Italy), which is the data controller for all personal data processed through this platform. For full details on how your data is collected, used and protected, please read our Privacy Policy.